NEW YORK ─ Salt Lake City-based Sera Prognostics announced on Tuesday that it is partnering with health insurer Anthem and its HealthCore subsidiary to conduct a study to determine whether Sera's PreTRM test, along with clinical interventions, can lead to improved health for newborns and mothers.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.